Illustrative comparative risksa (95% CI) | Relative effect (95% CI) | No of participants (studies) | Quality of the evidence (GRADE) | ||
---|---|---|---|---|---|
Assumed risk | Corresponding risk | ||||
No surgery group | Surgery group | ||||
Visual acuity follow-up | The mean visual acuity on follow-up ranged across control groups from 0.01 to 0.41 | The mean visual acuity on follow-up in the intervention groups was 0.44 higher (0.07 to 0.81 higher) | SMD 0.44 (0.07 to 0.81) | 262 (4 studies) | ⊕⊕⊝⊝ Lowb, c, d, e |
Change in epithelial area (mm2) | The mean change in epithelial area ranged across control groups from 26mm2 to 48mm2 | The mean change in epithelial area in the intervention groups was 1.37 higher (0.4 to 2.34 higher) | SMD 1.37 (0.40 to 2.34) | 68 (2 studies) | ⊕⊕⊝⊝ Lowb, c, d |
Healed epithelial defect | Medium risk population | RR 1.22 (1.02 to 1.46) | 68 (2 studies) | ⊕⊕⊝⊝ Lowb, c, d | |
758 per 1000 | 925 per 1000 (773 to 1000) | ||||
Wound/ocular infection | Medium risk population | RR 11.17 (1.28 to 597.85) | 173 (2 studies) | ⊕⊕⊕⊝ Moderateb, d | |
0 per 1000 | 0 per 1000 (0 to 0) | ||||
Symblepharon follow-up | Medium risk population | RR 0.55 (0.26 to 1.15) | 312 (5 studies) | ⊕⊕⊕⊝ Moderatec, d | |
610 per 1000 | 336 per 1000 (159 to 701) | ||||
Ectropion follow-up | Medium risk population | RR 7.30 (0.80 to 66.42) | 259 (3 studies) | ⊕⊕⊝⊝ Lowb, c, e | |
67 per 1000 | 487 per 1000 (53 to 1000) | ||||
Corneal vascularization follow-up | Medium risk population | RR 0.64 (0.32 to 1.28) | 336 (6 studies) | ⊕⊕⊕⊝ Moderateb, c | |
42 per 1000 | 17 per 1000 (3 to 105) |